Dr. Dedes is a founding member of the Society of Interventional Oncology and a director of the Endovascular Interventional Radiology department at the Interbalkan European Medical Center in Thessaloniki, Greece.
Cosmos CEO Grigorios Siokas is keen on Dedes’ elevation to the board, citing his healthcare expertise.
“Dr. Ioannis Dedes brings a wealth of experience to our group,” noted Siokas in a statement. “Dr. Dedes’s addition to our board will provide strategic and tactical support to our enterprise healthcare process, as well as our business development.”
Dedes’ appointment follows the recent addition of Anastasios Tzikas, the former CEO of Singular Northern Greece SA, one of Greece’s largest software vendors, to the Cosmos board.
Cosmos is an international pharmaceutical company with offices and distribution centers in Greece and the United Kingdom.
Cosmos shares slipped slightly to close at $6.99 on Tuesday.
Contact Ellen Kelleher at [email protected]veinvestors.com